Gasporox AB (publ)
Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers Instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha… Read more
Market Cap & Net Worth: Gasporox AB (publ) (GPX)
Gasporox AB (publ) (ST:GPX) has a market capitalization of $6.19 Million (Skr69.40 Million) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #33903 globally and #529 in its home market, demonstrating a 4.80% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Gasporox AB (publ)'s stock price Skr7.42 by its total outstanding shares 9353246 (9.35 Million).
Gasporox AB (publ) Market Cap History: 2016 to 2026
Gasporox AB (publ)'s market capitalization history from 2016 to 2026. Data shows change from $12.42 Million to $6.19 Million (-5.24% CAGR).
Gasporox AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Gasporox AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.21x
Gasporox AB (publ)'s market cap is 0.21 times its annual revenue
1.12x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $12.42 Million | $2.24 Million | -$3.76 Million | 5.55x | N/A |
| 2017 | $13.01 Million | $5.03 Million | -$5.13 Million | 2.59x | N/A |
| 2018 | $6.09 Million | $6.29 Million | -$6.32 Million | 0.97x | N/A |
| 2019 | $13.09 Million | $10.21 Million | -$7.17 Million | 1.28x | N/A |
| 2020 | $12.84 Million | $12.45 Million | -$4.36 Million | 1.03x | N/A |
| 2021 | $9.92 Million | $15.74 Million | -$5.39 Million | 0.63x | N/A |
| 2022 | $8.46 Million | $21.45 Million | -$4.56 Million | 0.39x | N/A |
| 2023 | $11.21 Million | $31.43 Million | -$1.25 Million | 0.36x | N/A |
| 2024 | $7.21 Million | $34.10 Million | -$2.68 Million | 0.21x | N/A |
Competitor Companies of GPX by Market Capitalization
Companies near Gasporox AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to Gasporox AB (publ) by market ranking:
- Keyence (PINK:KYCCF): Ranked #314 globally with a market cap of $67.95 Billion USD.
- Coherent Inc (NYSE:COHR): Ranked #527 globally with a market cap of $40.51 Billion USD.
- COHERENT CORP. (F:H7B): Ranked #533 globally with a market cap of $40.03 Billion USD ( €39.00 Billion EUR).
- Garmin Ltd (NYSE:GRMN): Ranked #556 globally with a market cap of $38.55 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #314 | Keyence | PINK:KYCCF | $67.95 Billion | $363.01 |
| #527 | Coherent Inc | NYSE:COHR | $40.51 Billion | $245.80 |
| #533 | COHERENT CORP. | F:H7B | $40.03 Billion | €223.00 |
| #556 | Garmin Ltd | NYSE:GRMN | $38.55 Billion | $235.10 |
Gasporox AB (publ) Historical Marketcap From 2016 to 2026
Between 2016 and today, Gasporox AB (publ)'s market cap moved from $12.42 Million to $ 6.19 Million, with a yearly change of -5.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr6.19 Million | -0.80% |
| 2025 | Skr6.24 Million | -13.53% |
| 2024 | Skr7.21 Million | -35.69% |
| 2023 | Skr11.21 Million | +32.51% |
| 2022 | Skr8.46 Million | -14.71% |
| 2021 | Skr9.92 Million | -22.73% |
| 2020 | Skr12.84 Million | -1.91% |
| 2019 | Skr13.09 Million | +115.07% |
| 2018 | Skr6.09 Million | -53.21% |
| 2017 | Skr13.01 Million | +4.70% |
| 2016 | Skr12.42 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Gasporox AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.19 Million USD |
| MoneyControl | $6.19 Million USD |
| MarketWatch | $6.19 Million USD |
| marketcap.company | $6.19 Million USD |
| Reuters | $6.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.